UniProt ID | GOGA2_HUMAN | |
---|---|---|
UniProt AC | Q08379 | |
Protein Name | Golgin subfamily A member 2 | |
Gene Name | GOLGA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1002 | |
Subcellular Localization |
Golgi apparatus, cis-Golgi network membrane Peripheral membrane protein . Cytoplasm, cytoskeleton, spindle pole . Peripheral membrane protein associated with cis-Golgi stacks (By similarity). Associates with the mitotic spindle during mitosis (PubM |
|
Protein Description | Peripheral membrane component of the cis-Golgi stack that acts as a membrane skeleton that maintains the structure of the Golgi apparatus, and as a vesicle thether that facilitates vesicle fusion to the Golgi membrane. Together with p115/USO1 and STX5, involved in vesicle tethering and fusion at the cis-Golgi membrane to maintain the stacked and inter-connected structure of the Golgi apparatus. Plays a central role in mitotic Golgi disassembly: phosphorylation at Ser-37 by CDK1 at the onset of mitosis inhibits the interaction with p115/USO1, preventing tethering of COPI vesicles and thereby inhibiting transport through the Golgi apparatus during mitosis (By similarity). Also plays a key role in spindle pole assembly and centrosome organization. [PubMed: 26165940 Promotes the mitotic spindle pole assembly by activating the spindle assembly factor TPX2 to nucleate microtubules around the Golgi and capture them to couple mitotic membranes to the spindle: upon phosphorylation at the onset of mitosis, GOLGA2 interacts with importin-alpha via the nuclear localization signal region, leading to recruit importin-alpha to the Golgi membranes and liberate the spindle assembly factor TPX2 from importin-alpha. TPX2 then activates AURKA kinase and stimulates local microtubule nucleation. Upon filament assembly, nascent microtubules are further captured by GOLGA2, thus linking Golgi membranes to the spindle] | |
Protein Sequence | MWPQPRLPPRPAMSEETRQSKLAAAKKKLREYQQRNSPGVPTGAKKKKKIKNGSNPETTTSGGCHSPEDTPKDNAATLQPSDDTVLPGGVPSPGASLTSMAASQNHDADNVPNLMDETKTFSSTESLRQLSQQLNGLVCESATCVNGEGPASSANLKDLESRYQQLAVALDSSYVTNKQLNITIEKLKQQNQEITDQLEEEKKECHQKQGALREQLQVHIQTIGILVSEKAELQTALAHTQHAARQKEGESEDLASRLQYSRRRVGELERALSAVSTQQKKADRYNKELTKERDALRLELYKNTQSNEDLKQEKSELEEKLRVLVTEKAGMQLNLEELQKKLEMTELLLQQFSSRCEAPDANQQLQQAMEERAQLEAHLGQVMESVRQLQMERDKYAENLKGESAMWRQRMQQMSEQVHTLREEKECSMSRVQELETSLAELRNQMAEPPPPEPPAGPSEVEQQLQAEAEHLRKELEGLAGQLQAQVQDNEGLSRLNREQEERLLELERAAELWGEQAEARRQILETMQNDRTTISRALSQNRELKEQLAELQSGFVKLTNENMEITSALQSEQHVKRELGKKLGELQEKLSELKETVELKSQEAQSLQQQRDQYLGHLQQYVAAYQQLTSEKEVLHNQLLLQTQLVDQLQQQEAQGKAVAEMARQELQETQERLEAATQQNQQLRAQLSLMAHPGEGDGLDREEEEDEEEEEEEAVAVPQPMPSIPEDLESREAMVAFFNSAVASAEEEQARLRGQLKEQRVRCRRLAHLLASAQKEPEAAAPAPGTGGDSVCGETHRALQGAMEKLQSRFMELMQEKADLKERVEELEHRCIQLSGETDTIGEYIALYQSQRAVLKERHREKEEYISRLAQDKEEMKVKLLELQELVLRLVGDRNEWHGRFLAAAQNPADEPTSGAPAPQELGAANQQGDLCEVSLAGSVEPAQGEAREGSPRDNPTAQQIMQLLREMQNPRERPGLGSNPCIPFFYRADENDEVKITVI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MWPQPRLPPRPAMSE CCCCCCCCCCCCCCH | 24.92 | 16097034 | |
14 | Phosphorylation | LPPRPAMSEETRQSK CCCCCCCCHHHHHHH | 34.09 | 28555341 | |
18 | Methylation | PAMSEETRQSKLAAA CCCCHHHHHHHHHHH | 41.89 | 20421892 | |
20 | Phosphorylation | MSEETRQSKLAAAKK CCHHHHHHHHHHHHH | 26.75 | 16097034 | |
21 | Acetylation | SEETRQSKLAAAKKK CHHHHHHHHHHHHHH | 33.53 | 25953088 | |
25 | Phosphorylation | RQSKLAAAKKKLREY HHHHHHHHHHHHHHH | 20.70 | 18669648 | |
27 | Ubiquitination | SKLAAAKKKLREYQQ HHHHHHHHHHHHHHH | 52.92 | 24816145 | |
30 | Methylation | AAAKKKLREYQQRNS HHHHHHHHHHHHHCC | 49.83 | 20421892 | |
32 | Phosphorylation | AKKKLREYQQRNSPG HHHHHHHHHHHCCCC | 11.96 | 20860994 | |
35 | Methylation | KLREYQQRNSPGVPT HHHHHHHHCCCCCCC | 30.02 | 20421892 | |
37 | Dephosphorylation | REYQQRNSPGVPTGA HHHHHHCCCCCCCCH | 25.81 | 10769027 | |
37 | Phosphorylation | REYQQRNSPGVPTGA HHHHHHCCCCCCCCH | 25.81 | 30266825 | |
42 | Phosphorylation | RNSPGVPTGAKKKKK HCCCCCCCCHHCCCC | 47.57 | 23403867 | |
45 | Acetylation | PGVPTGAKKKKKIKN CCCCCCHHCCCCCCC | 67.48 | 25953088 | |
47 | Acetylation | VPTGAKKKKKIKNGS CCCCHHCCCCCCCCC | 59.60 | 7469369 | |
51 | Ubiquitination | AKKKKKIKNGSNPET HHCCCCCCCCCCCCC | 65.22 | - | |
54 | Phosphorylation | KKKIKNGSNPETTTS CCCCCCCCCCCCCCC | 59.61 | 25159151 | |
58 | Phosphorylation | KNGSNPETTTSGGCH CCCCCCCCCCCCCCC | 36.31 | 23663014 | |
59 | Phosphorylation | NGSNPETTTSGGCHS CCCCCCCCCCCCCCC | 19.80 | 25159151 | |
60 | Phosphorylation | GSNPETTTSGGCHSP CCCCCCCCCCCCCCC | 32.56 | 22115753 | |
61 | Phosphorylation | SNPETTTSGGCHSPE CCCCCCCCCCCCCCC | 30.97 | 22617229 | |
63 (in isoform 2) | Ubiquitination | - | 13.01 | 21906983 | |
66 | Phosphorylation | TTSGGCHSPEDTPKD CCCCCCCCCCCCCCC | 33.78 | 25159151 | |
70 | Phosphorylation | GCHSPEDTPKDNAAT CCCCCCCCCCCCCCC | 30.49 | 23663014 | |
77 | Phosphorylation | TPKDNAATLQPSDDT CCCCCCCCCCCCCCC | 24.42 | 20068231 | |
81 | Phosphorylation | NAATLQPSDDTVLPG CCCCCCCCCCCCCCC | 34.85 | 20068231 | |
84 | Phosphorylation | TLQPSDDTVLPGGVP CCCCCCCCCCCCCCC | 29.00 | 20068231 | |
92 | Phosphorylation | VLPGGVPSPGASLTS CCCCCCCCCCCCHHH | 33.29 | 29496963 | |
96 | Phosphorylation | GVPSPGASLTSMAAS CCCCCCCCHHHHHHH | 37.79 | 26074081 | |
98 | Phosphorylation | PSPGASLTSMAASQN CCCCCCHHHHHHHCC | 17.60 | 20068231 | |
99 | Phosphorylation | SPGASLTSMAASQNH CCCCCHHHHHHHCCC | 16.24 | 20068231 | |
103 | Phosphorylation | SLTSMAASQNHDADN CHHHHHHHCCCCCCC | 23.21 | 20068231 | |
118 | Phosphorylation | VPNLMDETKTFSSTE CCCCCCHHCCCCCHH | 30.99 | 30278072 | |
120 | Phosphorylation | NLMDETKTFSSTESL CCCCHHCCCCCHHHH | 35.85 | 27732954 | |
122 | Phosphorylation | MDETKTFSSTESLRQ CCHHCCCCCHHHHHH | 41.40 | 30108239 | |
123 | Phosphorylation | DETKTFSSTESLRQL CHHCCCCCHHHHHHH | 31.81 | 30108239 | |
124 | Phosphorylation | ETKTFSSTESLRQLS HHCCCCCHHHHHHHH | 28.53 | 30108239 | |
126 | Phosphorylation | KTFSSTESLRQLSQQ CCCCCHHHHHHHHHH | 29.01 | 30108239 | |
131 | Phosphorylation | TESLRQLSQQLNGLV HHHHHHHHHHHCCCC | 13.93 | 27251275 | |
152 | Phosphorylation | VNGEGPASSANLKDL CCCCCCCCCCCHHHH | 32.87 | 27251275 | |
163 | Phosphorylation | LKDLESRYQQLAVAL HHHHHHHHHHHHHHH | 15.19 | 27642862 | |
174 | Phosphorylation | AVALDSSYVTNKQLN HHHHCCHHHCCHHHC | 18.42 | 25884760 | |
195 | Phosphorylation | KQQNQEITDQLEEEK HHHCHHHHHHHHHHH | 19.55 | 30619164 | |
202 (in isoform 1) | Ubiquitination | - | 58.09 | 21906983 | |
202 | Ubiquitination | TDQLEEEKKECHQKQ HHHHHHHHHHHHHHH | 58.09 | 21906983 | |
220 | Ubiquitination | REQLQVHIQTIGILV HHHHHHHHHHHHHHH | 3.98 | 24816145 | |
247 | Ubiquitination | TQHAARQKEGESEDL HHHHHHHCCCCCHHH | 63.23 | 24816145 | |
251 | Phosphorylation | ARQKEGESEDLASRL HHHCCCCCHHHHHHH | 47.47 | 21406692 | |
253 | Ubiquitination | QKEGESEDLASRLQY HCCCCCHHHHHHHHH | 57.73 | 24816145 | |
256 | Phosphorylation | GESEDLASRLQYSRR CCCHHHHHHHHHHHH | 40.60 | 21406692 | |
273 | Phosphorylation | GELERALSAVSTQQK HHHHHHHHHHHHHHH | 26.16 | 28450419 | |
274 | Ubiquitination | ELERALSAVSTQQKK HHHHHHHHHHHHHHH | 10.50 | 24816145 | |
276 | Phosphorylation | ERALSAVSTQQKKAD HHHHHHHHHHHHHHH | 21.88 | 25072903 | |
277 | Phosphorylation | RALSAVSTQQKKADR HHHHHHHHHHHHHHH | 28.55 | 25072903 | |
280 | 2-Hydroxyisobutyrylation | SAVSTQQKKADRYNK HHHHHHHHHHHHHHH | 39.86 | - | |
280 | Ubiquitination | SAVSTQQKKADRYNK HHHHHHHHHHHHHHH | 39.86 | 24816145 | |
302 | Ubiquitination | ALRLELYKNTQSNED HHHHHHHHCCCCCHH | 67.17 | - | |
307 | Ubiquitination | LYKNTQSNEDLKQEK HHHCCCCCHHHHHHH | 36.66 | 24816145 | |
320 | Ubiquitination | EKSELEEKLRVLVTE HHHHHHHHHHHHHHH | 32.02 | - | |
320 | 2-Hydroxyisobutyrylation | EKSELEEKLRVLVTE HHHHHHHHHHHHHHH | 32.02 | - | |
415 | Phosphorylation | RQRMQQMSEQVHTLR HHHHHHHHHHHHHHH | 22.12 | 28555341 | |
420 | Phosphorylation | QMSEQVHTLREEKEC HHHHHHHHHHHHHHH | 28.75 | 28509920 | |
426 | Phosphorylation | HTLREEKECSMSRVQ HHHHHHHHHCHHHHH | 34.79 | 18669648 | |
437 | Phosphorylation | SRVQELETSLAELRN HHHHHHHHHHHHHHH | 41.48 | 30266825 | |
438 | Phosphorylation | RVQELETSLAELRNQ HHHHHHHHHHHHHHH | 19.06 | 30266825 | |
474 | Ubiquitination | AEAEHLRKELEGLAG HHHHHHHHHHHHHHH | 73.36 | - | |
532 | Methylation | LETMQNDRTTISRAL HHHHHHCHHHHHHHH | 41.12 | - | |
540 | Phosphorylation | TTISRALSQNRELKE HHHHHHHHCCHHHHH | 25.15 | 24719451 | |
546 | Ubiquitination | LSQNRELKEQLAELQ HHCCHHHHHHHHHHH | 38.37 | - | |
577 | 2-Hydroxyisobutyrylation | LQSEQHVKRELGKKL HHCHHHHHHHHHHHH | 37.72 | - | |
583 | Ubiquitination | VKRELGKKLGELQEK HHHHHHHHHHHHHHH | 60.98 | 29967540 | |
590 | Ubiquitination | KLGELQEKLSELKET HHHHHHHHHHHHHHH | 44.33 | 2190698 | |
590 (in isoform 1) | Ubiquitination | - | 44.33 | 21906983 | |
595 | Ubiquitination | QEKLSELKETVELKS HHHHHHHHHHHHHHH | 47.49 | - | |
690 | Phosphorylation | QQLRAQLSLMAHPGE HHHHHHHHHHCCCCC | 12.20 | 22067460 | |
774 | Phosphorylation | RLAHLLASAQKEPEA HHHHHHHHHHCCCHH | 31.07 | 18491316 | |
777 | Ubiquitination | HLLASAQKEPEAAAP HHHHHHHCCCHHCCC | 74.97 | - | |
780 | Ubiquitination | ASAQKEPEAAAPAPG HHHHCCCHHCCCCCC | 52.62 | 24816145 | |
788 | Phosphorylation | AAAPAPGTGGDSVCG HCCCCCCCCCCCCCH | 36.61 | 27251275 | |
792 | Phosphorylation | APGTGGDSVCGETHR CCCCCCCCCCHHHHH | 23.68 | 25849741 | |
795 | Ubiquitination | TGGDSVCGETHRALQ CCCCCCCHHHHHHHH | 40.45 | 32015554 | |
797 | Phosphorylation | GDSVCGETHRALQGA CCCCCHHHHHHHHHH | 11.27 | 27251275 | |
807 | Ubiquitination | ALQGAMEKLQSRFME HHHHHHHHHHHHHHH | 38.45 | 32015554 | |
819 | Ubiquitination | FMELMQEKADLKERV HHHHHHHHHHHHHHH | 30.24 | - | |
819 | 2-Hydroxyisobutyrylation | FMELMQEKADLKERV HHHHHHHHHHHHHHH | 30.24 | - | |
822 | Ubiquitination | LMQEKADLKERVEEL HHHHHHHHHHHHHHH | 8.09 | 32015554 | |
834 | Ubiquitination | EELEHRCIQLSGETD HHHHHHHHHHCCCCC | 4.68 | 24816145 | |
850 | Phosphorylation | IGEYIALYQSQRAVL HHHHHHHHHHHHHHH | 9.33 | - | |
864 | 2-Hydroxyisobutyrylation | LKERHREKEEYISRL HHHHHHHHHHHHHHH | 56.66 | - | |
881 | Ubiquitination | DKEEMKVKLLELQEL CHHHHHHHHHHHHHH | 41.66 | - | |
937 | Phosphorylation | QGDLCEVSLAGSVEP CCCCEEEEECCCCCC | 7.10 | 24275569 | |
941 | Phosphorylation | CEVSLAGSVEPAQGE EEEEECCCCCCCCCC | 20.07 | 17081983 | |
947 | Phosphorylation | GSVEPAQGEAREGSP CCCCCCCCCCCCCCC | 32.41 | 18669648 | |
953 | Phosphorylation | QGEAREGSPRDNPTA CCCCCCCCCCCCHHH | 16.41 | 25159151 | |
959 | Phosphorylation | GSPRDNPTAQQIMQL CCCCCCHHHHHHHHH | 43.27 | 22617229 | |
981 | Phosphorylation | RERPGLGSNPCIPFF CCCCCCCCCCCEEEE | 42.51 | 26363069 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GOGA2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND SER-438, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND SER-438, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND MASSSPECTROMETRY. | |
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20, AND MASSSPECTROMETRY. |